Skip to main content

Table 4 Indications for amputation

From: The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design

 

N

% Amps

Pain

13

86.67%

Gangrene

6

40.00%

Disease progression

5

33.33%

Local infection

5

33.33%

Systemic infection

1

6.67%

Failure to heal

1

6.67%

Osteomyelitis

0

0.00%

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us